University of Medicine and Dentistry of New Jersey

University of Medicine and Dentistry of New Jersey

University of Medicine and Dentistry of New Jersey

Overview
Date Founded

1970

Headquarters

65 Bergen Street,Room 1328,Newark, NJ 07107-3001

Charitable Causes

Higher Education & Universities

Company Description

The University of Medicine and Dentistry of New Jersey (UMDNJ) was a state-run health sciences institution of New Jersey, United States. It had eight distinct academic units. It formed an academic health sciences centre.

Contact Data
Trying to get in touch with decision makers at University of Medicine and Dentistry of New Jersey? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Senior Associate Dean for Research

Member-Deans Development Council

Interim Dean

Director of Financial Aid

Director

Director

Board of Directors

Professor, Department of Preventitive Medicine & Community Health at University of Medicine and Dentistry of New Jersey

Distinguished Alumni
Andrew L. Pecora is now Founder at COTA, Inc.
Gregory J. Mulford is now Medical Director, Post Acute Service Line at Atlantic Health System, Inc.
Paths to University of Medicine and Dentistry of New Jersey
Potential Connections via
Relationship Science
You
University of Medicine and Dentistry of New Jersey
Recent Transactions
Details Hidden

Rutgers University purchases University of Medicine and Dentistry of New Jersey

Details Hidden

Centene Corporation purchases University Health Plans, Inc. from University of Medicine and Dentistry of New Jersey

Details Hidden

Horizon Healthcare Services, Inc. purchases University of Health Plans /Commercial Point-of-Service from University of Medicine and Dentistry of New Jersey

Transaction Advisors
Legal Advisor

Advised onCentene Corporation purchases University Health Plans, Inc. from University of Medicine and Dentistry of New Jersey

Advisors & Consultants
Advisor

Managing Partner-Edison, New Jersey at CohnReznick LLP

Advisor

Former Chief Civil/Structural/Architectural Engineer at Burns & Roe Enterprises, Inc.

Clients

Since its beginnings as the biomedical business of Takara Shuzo Co., Ltd. (now Takara Holdings Inc.), Takara Bio has developed biotechnology-related businesses with a focus on genetic engineering technologies. At present, we have three business segments. In Japan, the Genetic engineering research business has pioneered the introduction and sale of a gene amplification system known as PCR (Polymerase Chain Reaction). This business provides research reagents, scientific instruments, and contract research services that are essential for leading-edge biotechnology research. Today, the sales network of this business boasts a global reach, encompassing North America, Europe, and emerging Asian countries. Meanwhile, since being the first to succeed in the large-scale production of Bunashimeji mushrooms in 1970, the AgriBio business has developed a business centered on technologies for the large-scale production of mushrooms. For example, it produces and sells Hatakeshimeji and Honshimeji mushrooms. Also, the business provides customers with health food products whose functionality has been proven through the use of biotechnology. These include Gagome kombu (kelp) fucoidan, agar-derived agaro-oligosaccharide, and Ashitaba (angelica herb) chalcone. The third arm of our business is the Gene medicine business, which applies technologies developed by the Genetic engineering research business to the medical field. The business develops and commercializes leading-edge medical technologies, such as cell and gene therapies for cancer and AIDS. Our business strategy is to invest the stable income generated by the Genetic engineering research and AgriBio business into the Gene medicine business in order to develop gene medicine technologies, thereby expanding our future earnings. Takara Bio Inc. contributes to the health of mankind by making revolutionary biomedical technology, such as gene therapy, a reality.

Non-Profit Donations & Grants Received
Investments
Details Hidden

PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.

Details Hidden

WellGen, Inc. develops products for inflammation-based diseases. The company was founded in 1997 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by University of Medicine and Dentistry of New Jersey. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of University of Medicine and Dentistry of New Jersey's profile does not indicate a business or promotional relationship of any kind between RelSci and University of Medicine and Dentistry of New Jersey.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/university-of-medicine-and-dentistry-of-new-jersey-24439388
  • https://relationshipscience.com/organization/university-of-medicine-and-dentistry-of-new-jersey-24439388